[Complete parenteral alimentation after major digestive surgery using lEB 51-Trivé 1000].
The aim of this work is to study the tolerance and the effectiveness of a complete intravenous feeding with EB 51 - Trivemil in immediate post-operative period, in 40 patients undergoing major digestive surgery. The patients were divided into three groups:--first group: 25 patients were given daily an average of 2900 calories 1500 of which via the Trivemil, during the first four post-operative days.--Second group: 5 patients received the same daily caloric dose but because of local complications, drips were maintained until the 7th day.--Third group: 10 patients received an average of 3100 calories daily 2000 of which via the Trivemil. The tolerance was evaluated by a clinical observation (blood pressure - nausea - cutaneous manifestations - temperature) and by a biological observation (hemolysis - free hemoglobin - plasma clearing). The use and effectiveness of the nutrient was evaluated - globally - by a study of body weight according to the hydro-electrolytic balance and then - individually - by the balance of the intakes and secretions of the glucides, lipids and proteids. The tolerance was excellent in all the cases, the weight remained stable, the nitrogen retention was constant mainly in the third group where it seemed to depend on the initial total energetic intake.
[Complete parenteral alimentation after major digestive surgery using lEB 51-Trivé 1000]. The aim of this work is to study the tolerance and the effectiveness of a complete intravenous feeding with EB 51 - Trivemil in immediate post-operative period, in 40 patients undergoing major digestive surgery. The patients were divided into three groups:--first group: 25 patients were given daily an average of 2900 calories 1500 of which via the Trivemil, during the first four post-operative days.--Second group: 5 patients received the same daily caloric dose but because of local complications, drips were maintained until the 7th day.--Third group: 10 patients received an average of 3100 calories daily 2000 of which via the Trivemil. The tolerance was evaluated by a clinical observation (blood pressure - nausea - cutaneous manifestations - temperature) and by a biological observation (hemolysis - free hemoglobin - plasma clearing). The use and effectiveness of the nutrient was evaluated - globally - by a study of body weight according to the hydro-electrolytic balance and then - individually - by the balance of the intakes and secretions of the glucides, lipids and proteids. The tolerance was excellent in all the cases, the weight remained stable, the nitrogen retention was constant mainly in the third group where it seemed to depend on the initial total energetic intake.